Kevin Zeidan
Managing Director at Trinity Capital
San Francisco, California
Kevin Zeidan, Managing Director at Trinity Capital is an active investor based in San Francisco, California. This profile covers what Kevin Zeidan backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPEVenture Debt
- Stages
- SeedSeries ASeries BLate Stage Venture
- Invests in
- FintechHealthcare & BiotechBiotech & PharmaMedTech & Medical DevicesEdTech
- Location
- San Francisco, California
- Typical check
- $2M
- Past investments
- 92
Notable investments
CapLinked
Melinta
ChromaDex
AMSC
UdacityNeos TherapeuticsMerrimack Pharmaceuticals
Constellation Pharmaceuticals
CytRx
Antares Pharma
Asensus Surgical
Aprecia PharmaceuticalsHow to reach Kevin Zeidan
Angels and operators like Kevin Zeidan reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Kevin Zeidan
Frequently Asked Questions
What does Kevin Zeidan invest in?
Kevin Zeidan invests in Fintech, Healthcare & Biotech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Kevin Zeidan invest at?
Kevin Zeidan typically invests at Seed, Series A, Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Kevin Zeidan's typical check size?
Kevin Zeidan typically writes checks around $2M. Use it as a signal for whether your raise fits their stage.
How do I contact Kevin Zeidan?
Unlock Kevin Zeidan's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.